365 related articles for article (PubMed ID: 31650293)
1. Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer.
Vesty A; Gear K; Biswas K; Mackenzie BW; Taylor MW; Douglas RG
Support Care Cancer; 2020 Jun; 28(6):2683-2691. PubMed ID: 31650293
[TBL] [Abstract][Full Text] [Related]
2. Mucosal microflora in head and neck cancer patients.
Almståhl A; Finizia C; Carlén A; Fagerberg-Mohlin B; Alstad T
Int J Dent Hyg; 2018 Nov; 16(4):459-466. PubMed ID: 29766652
[TBL] [Abstract][Full Text] [Related]
3. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
[TBL] [Abstract][Full Text] [Related]
4. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
Zhang L; San Valentin EMD; John TM; Jenq RR; Do KA; Hanna EY; Peterson CB; Reyes-Gibby CC
Cancer; 2024 Jan; 130(1):150-161. PubMed ID: 37688396
[TBL] [Abstract][Full Text] [Related]
5. Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy.
Hou J; Zheng H; Li P; Liu H; Zhou H; Yang X
Radiother Oncol; 2018 Oct; 129(1):44-51. PubMed ID: 29735410
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
Hong BY; Sobue T; Choquette L; Dupuy AK; Thompson A; Burleson JA; Salner AL; Schauer PK; Joshi P; Fox E; Shin DG; Weinstock GM; Strausbaugh LD; Dongari-Bagtzoglou A; Peterson DE; Diaz PI
Microbiome; 2019 Apr; 7(1):66. PubMed ID: 31018870
[TBL] [Abstract][Full Text] [Related]
7. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment.
Gaetti-Jardim E; Jardim ECG; Schweitzer CM; da Silva JCL; Oliveira MM; Masocatto DC; Dos Santos CM
Arch Oral Biol; 2018 Jun; 90():45-52. PubMed ID: 29533791
[TBL] [Abstract][Full Text] [Related]
8. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
9. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
10. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy.
Jehmlich N; Stegmaier P; Golatowski C; Salazar MG; Rischke C; Henke M; Völker U
J Proteomics; 2015 Jul; 125():98-103. PubMed ID: 25997676
[TBL] [Abstract][Full Text] [Related]
11. Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients.
Bruno JS; Heidrich V; Knebel FH; de Molla VC; Parahyba CJ; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Camargo AA; Fregnani ER
Sci Rep; 2022 Oct; 12(1):17527. PubMed ID: 36266464
[TBL] [Abstract][Full Text] [Related]
12. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.
Stokman MA; Spijkervet FK; Burlage FR; Dijkstra PU; Manson WL; de Vries EG; Roodenburg JL
Br J Cancer; 2003 Apr; 88(7):1012-6. PubMed ID: 12671696
[TBL] [Abstract][Full Text] [Related]
13. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study.
Wijers OB; Levendag PC; Harms ER; Gan-Teng AM; Schmitz PI; Hendriks WD; Wilims EB; van der Est H; Visch LL
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):343-52. PubMed ID: 11380220
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.
Oba MK; Innocentini LMAR; Viani G; Ricz HMA; de Carvalho Reis T; Ferrari TC; de Macedo LD
Support Care Cancer; 2021 Jan; 29(1):127-134. PubMed ID: 32318870
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
16. Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study.
Musha A; Hirai C; Kitada Y; Tsunoda A; Shimada H; Kubo N; Kawamura H; Okano N; Sato H; Okada K; Adachi A; Yokoo S; Chikamatsu K; Ohno T
Radiother Oncol; 2022 Feb; 167():65-71. PubMed ID: 34902372
[TBL] [Abstract][Full Text] [Related]
17. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy.
Epstein JB; Gorsky M; Guglietta A; Le N; Sonis ST
Cancer; 2000 Dec; 89(11):2258-65. PubMed ID: 11147596
[TBL] [Abstract][Full Text] [Related]
18. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients.
Spijkervet FK; Van Saene HK; Van Saene JJ; Panders AK; Vermey A; Mehta DM; Fidler V
J Surg Oncol; 1991 Mar; 46(3):167-73. PubMed ID: 2011028
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
[TBL] [Abstract][Full Text] [Related]
20. A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy.
El-Sayed S; Epstein J; Minish E; Burns P; Hay J; Laukkanen E
Head Neck; 2002 Jan; 24(1):6-15. PubMed ID: 11774397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
